Tranexamic Acid (TXA) in Hip Arthroscopy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The primary goal of this study will be to determine if perioperative IV Tranexamic Acid (TXA) administration will reduce intra-operative bleeding and subsequently improve visual clarity during surgery and reduce operative traction time in patients undergoing hip arthroscopy. Additionally, this study aims to determine whether IV TXA injections will reduce post-operative pain and affect hip-specific patient-reported outcomes in patients undergoing hip arthroscopy.
Epistemonikos ID: 041493f898b6bb51c6896dc3163be5701e73a491
First added on: Feb 19, 2024